'Migraine Experience' Debuts Excedrin Advertising By Glaxo/Novartis JV
This article was originally published in The Tan Sheet
Executive Summary
Excedrin Migraine’s multi-channel campaign, the first major promotion for the brand since moving into the Glaxo/Novartis JV, incorporates "augmented reality" technology for a window into the struggles of migraine sufferers.
You may also be interested in...
GSK Sees Excedrin Sales Growth As Consumers Visualize Headache Pain
Excedrin Extra Strength US sales for the 12 months ending Aug. 12 were up 4.07% to $77.2m, but those figures don't include the 12,000 free packages of Excedrin gel tablets consumers ordered during GSK's the Limited Edition promotion. The firm offered Excedrin in packages marked with causes consumers commonly link with headaches: commuting, bad dating and "adulting."
GSK Sees Excedrin Sales Growth As Consumers Visualize Headache Pain
Excedrin Extra Strength US sales for the 12 months ending Aug. 12 were up 4.07% to $77.2m, but those figures don't include the 12,000 free packages of Excedrin gel tablets consumers ordered during GSK's the Limited Edition promotion. The firm offered Excedrin in packages marked with causes consumers commonly link with headaches: commuting, bad dating and "adulting."
Revamped Novartis In Good Shape At 3Q Ahead Of CEO Succession
Novartis beat third-quarter forecasts, flagged its strengthening drug portfolio, and said its CEO transition remains on track for February 2018, but a decision on its eye care division awaits.